CSP Lifesciences

What CSP Lifesciences does

CSP Lifesciences is a privately-held integrated pharmaceutical company headquartered in Ahmedabad, Gujarat, India, operating a front-end marketing and export model across 19 countries. The company sources finished pharmaceutical formulations from Indian manufacturers and distributes injectables, tablets, capsules, ointments/creams/gels, and syrups through wholly-owned subsidiaries in the USA, Peru, and the Philippines, and through associate partners in the UAE, Uzbekistan, Sri Lanka, Tanzania, Ecuador, Kenya, and French West Africa. Its portfolio covers oncology, anti-diabetic, cardiology, gynecology, pain and analgesics, anti-infective, vitamins, minerals, nutrients, gastro-intestinal, anti-osteoporosis, anti-malarial, anti-asthmatics, and anti-allergy categories, with specialty capabilities in lyophilized vials, propofol, and dry powder injectables for oncology and cardiovascular use.

The business spans four stated verticals — Manufacturing, Sourcing, Distribution, and Marketing — with distribution and marketing the primary revenue engines. CSP runs enterprise field sales and channel-partner models targeting hospitals, pharmacies, and healthcare providers; pricing is quote-based and not publicly disclosed. The company has extended beyond prescription pharma into consumer dermatology through Bioreva Skincare and Uncap Skincare sub-brands, and has begun precision-medicine collaboration in the USA and R&D partnerships with local healthcare experts in East Africa. Leadership is concentrated in a 17-person team, with CEO Chandan Purohit (ex-CFO Claris Lifesciences) leading strategy, COO Urvish Shastri running operations, and Rakesh Nair leading the Philippines subsidiary. The stated objective is to scale to 25 countries within five years.

Name

CSP Lifesciences

Legal name

CSP Lifesciences

Website

https://csplifesciences.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

CSP Lifesciences is an India-headquartered pharmaceutical marketing and export company that sources finished formulations from Indian manufacturers and distributes injectables, tablets, capsules, ointments, and syrups across 15+ therapeutic categories in 19 countries via subsidiaries in the USA, Peru, and the Philippines.

Ownership category

akta.pro rank

Product category

Pharmaceutical Formulations

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

akta.pro secondary industries

Cardiology & Vascular Specialty Pharmaceuticals (HLAIACAG), Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD), Vitamins & Minerals (Single Nutrients) (CRADAGAB)

Keywords

• Pharmaceutical formulations
• Injectable manufacturing
• Oncology generics
• Pharma export
• Finished dosage forms

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: CSP Lifesciences generates revenue through manufacturing, marketing, and distribution of finished pharmaceutical formulations including injectables, tablets, capsules, syrups, and ointments across multiple therapeutic areas
2. International Business Development: Revenue generated through international sales and marketing operations with subsidiaries in USA, Peru, Philippines and associate relationships across multiple emerging markets
3. Pharmaceutical Export: Export of high-quality, affordable medicines to global markets, leveraging India's pharmaceutical manufacturing expertise

Go-to-market motion3 records

Distribution channels3 records

Marketing channels3 records

Core offering

CSP Lifesciences manufactures, sources, and markets finished pharmaceutical formulations including injectables (ampoules, liquid vials, lyophilized vials, propofol, dry powders), tablets, capsules, ointments/creams/gels, and syrups across 15+ therapeutic areas such as oncology, anti-diabetics, cardiology, gynecology, pain management, and anti-infectives. The company distributes these products globally through subsidiaries and associate partners in 19 countries, serving healthcare providers, pharmacies, and hospitals.

Product overview

CSP Lifesciences is an integrated pharmaceutical company offering a comprehensive portfolio of pharmaceutical finished formulations across multiple delivery formats. The core product portfolio includes Injectables (comprising Ampoules, Liquid Vials, Lyophilized Vials, Propofol, and Dry Powders), Tablets, Capsules, Ointments/Creams/Gels, and Syrups. The company operates across four main verticals: Manufacturing, Sourcing, Distribution, and Marketing. Their therapeutic focus spans Oncology, Anti-Diabetics, Cardiology, Gynaecology, Pain and Analgesics, Anti-Infective, Vitamins, Minerals, Nutrients, Gastro-Intestinal, Anti-Osteoporosis, Anti-Malarial, Immunosuppressant, Anti-Asthmatics, Anti-Allergy, and Anti-Bacterial categories. Additionally, the company has expanded into consumer healthcare with skincare sub-brands Bioreva Skincare and Uncap Skincare.

Differentiator

Problem solved

Functional benefit

Brands

• Bioreva Skincare: Skincare brand under CSP Lifesciences Philippines offering dermatological products.
• Uncap Skincare

Products and services

• Injectables Pharmaceutical injectable products including ampoules, liquid vials, lyophilized vials, propofol, and dry powders for various therapeutic applications, marketed to healthcare providers and distributors.
• Ampoules Sterile injectable medications packaged in glass ampoules for accurate, sterile delivery of life-saving medications, intended for hospital and clinical use.
• Liquid Vials Ready-to-use injectable solutions packaged in vials across various therapeutic applications, supplied to healthcare providers.
• Lyophilized Vials Freeze-dried injectable formulations that retain stability and efficacy over extended periods and require reconstitution before administration; used for critical care and specialty medications.
• Propofol Anesthetic agent used for induction and maintenance of sedation in surgical and diagnostic procedures, providing rapid and controlled sedation; supplied to hospitals and surgical centers.
• Dry Powders Reconstitutable dry powder injectables including antibiotics, oncology drugs, cardiovascular medications, and other therapeutic agents requiring reconstitution before administration; marketed to hospitals and specialty providers.
• Tablets Pharmaceutical tablets in oncology, cardiovascular, anti-diabetic, anti-infective, pain management, and other therapeutic areas with multiple dosage strengths, supplied to pharmacies, hospitals, and distributors.
• Capsules Pharmaceutical capsules across anti-asthmatics, oncology, anti-infectives, pain management, gastrointestinal, and other therapeutic categories, sold to pharmacies, hospitals, and distributors.
• Ointments, Creams & Gels Topical pharmaceutical preparations including anti-inflammatory, antibacterial, antifungal, and anti-allergy ointments, creams, and gels sold to pharmacies and healthcare providers.
• Syrups Oral liquid formulations including suspensions and solutions for anti-infective, anti-bacterial, anti-allergy, gastrointestinal, and other therapeutic applications, sold to pharmacies and healthcare providers.
• Bioreva Skincare Dermatology skincare sub-brand under CSP Lifesciences Philippines offering dermatological products for various skin concerns.
• Uncap Skincare Modern skincare sub-brand combining natural ingredients with scientific formulations, marketed as clean, effective, and dermatologically tested for advanced skincare and hair growth solutions.

Quantifiable outcome

• Over 1200 finished pharmaceutical products in portfolio
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Indian Manufacturing FacilitiescoreStrategic or Co-development PartnerLeverages relationships with Indian pharmaceutical manufacturers to source and procure therapeutic products including capsules, tablets, injectables, dry powders, and liquids across oncology, cardiology, pain, GI, and diabetes therapeutic areas
• Global Pharmaceutical ManufacturerscoreStrategic or Co-development PartnerPartnerships with reputable global pharmaceutical manufacturers ensure latest advancements in medicine are accessible to healthcare providers and patients in markets including Sri Lanka and Ecuador
• Healthcare Providers and FacilitiescoreChannel Partner/ Reseller/ DistributorCollaborates with hospitals, pharmacies, and healthcare providers across 19 countries to ensure delivery of life-saving medications and healthcare products
• Kenyan Healthcare ExpertsminorStrategic or Co-development PartnerInvests in research and development, partnering with local healthcare experts to develop medications tailored to specific healthcare needs of Kenya and broader East African region

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Dr. Reddy's Laboratories: Indian pharmaceutical major with global generics business spanning injectables, orals, and biosimilars. Comparable to CSP in finished-formulation focus, India manufacturing base, and multi-country distribution, including emerging markets.
• Torrent Pharmaceuticals: Indian pharmaceutical company with strong presence in cardiology, diabetology, and gastrointestinal segments plus international operations. Comparable to CSP in therapeutic emphasis on chronic-disease categories and emerging-market focus.
• Aurobindo Pharma: Large Indian generic pharmaceutical manufacturer with substantial export and emerging-market business. Overlaps with CSP on therapeutic categories (oncology, cardiology, anti-infectives, anti-diabetics) and global distribution reach, though at much greater scale.
• Cipla: Major Indian pharmaceutical company with deep presence in respiratory, cardiology, anti-infective, and oncology segments and a strong emerging-market footprint. Comparable to CSP in therapeutic focus, India-based manufacturing, and export orientation.
• Cadila Healthcare (Zydus): Indian pharmaceutical group with broad generics portfolio spanning formulations, injectables, and biosimilars, with significant US and emerging-market presence. Comparable therapeutic and geographic mix to CSP's portfolio.
• Strides Pharma Science: Indian pharmaceutical manufacturer and exporter with a global footprint in regulated and emerging markets. Comparable to CSP in business model (manufacture and export of finished formulations), therapeutic breadth, and international distribution.
• Gland Pharma: India-based injectables-focused pharmaceutical company with strong presence in regulated and emerging markets. Directly comparable to CSP's injectable-led portfolio and export-oriented model across oncology, cardiology, and anti-infective categories.
• Claris Lifesciences: Indian sterile injectables manufacturer and exporter with global distribution, headquartered in Ahmedabad. Highly comparable to CSP Lifesciences given shared injectable focus, Ahmedabad base, and the fact that CSP's CEO previously held senior finance and strategy roles there.

Broad incumbents

• Sun Pharmaceutical Industries: Largest Indian pharmaceutical company with global generics, specialty, and branded businesses. Competes with CSP in many of the same therapeutic areas and geographies but at substantially larger scale and broader portfolio depth.
• Teva Pharmaceutical Industries: Global leader in generic pharmaceuticals with extensive emerging-market distribution. Comparable to CSP in product category (finished generic formulations) but operates at much larger scale and across many more regulated markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/csplifesciences

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CSP Lifesciences